RNU6-589P

Across TCGA pan-cancer cohorts, RNU6-589P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-589P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-589P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-589P expression acts as an unfavorable survival marker, although some lineages such as OV and STAD show a favorable association.

ACC, OV, and LUSC are the cancer types where RNU6-589P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	II,III,IV	0.114	0.869	<.001	45	view →
OV	DFS	Tertile	All	0.549	0.366	.008	42	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
STAD	OS	Tertile	All	0.559	0.315	.003	25	view →
LIHC	DFS	Tertile	All	0.174	0.454	.004	18	view →
KIRP	OS	Tertile	All	0.867	0.954	.004	15	view →
ESCA	OS	Median	III,IV	0.685	0.393	<.001	12	view →
READ	DFS	Tertile	II,III,IV	1.000	0.429	.022	12	view →
THCA	OS	Tertile	III,IV	0.307	0.957	.013	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-589P–ACC (OS)

Open the ACC breakdown →